VIGLIPTIN M 50/500 SR

VIGLIPTIN M 50/500 SR is a combination anti-diabetic formulation containing Vildagliptin 50 mg and Metformin 500 mg (Sustained Release). It is designed for the effective management of Type 2 Diabetes Mellitus, providing improved glycemic control with prolonged glucose-lowering action.

Key Benefits 

✔ Provides sustained blood sugar control
✔ Reduces fasting and post-prandial glucose levels
✔ Improves insulin response naturally
✔ Ensures prolonged action with SR formulation
✔ Suitable for long-term Type 2 diabetes management